Single Use Support has announced the appointment of Darren Verlenden as Chief Executive Officer, a strategic move to support the company’s ambitious global growth plans. Verlenden, who was previously Executive Vice President for the Process Solutions business at Merck KGaA
Bushu Pharma has been honoured with Frost & Sullivan’s 2024 APAC Customer Value Leadership Award for its outstanding contributions to the contract development and manufacturing organization (CDMO) industry. The Japan-based pharmaceutical and medical device manufacturer earned recognition for its comprehensive
Stephen Sheehan of Alkermes shares their new governance framework for high-performing CDMO partnerships. As Director of External Development & Manufacturing at Alkermes, Stephen Sheehan brings over a decade of experience in pharmaceutical development. Having transitioned from small to large molecules,
For early-stage biotech companies, securing funding marks a critical transition point, but the real challenge lies in turning plans into action. Ray Sison, Managing Partner at SCxCMC, who has worked with over 75 different clients since 2011, offers a practical
Falconer, a manufacturer of decorative printed folding cartons, has opened its second manufacturing facility in West Yorkshire. The new 15,000 sq ft site, which became fully operational on 17 November 2024, is set to enhance the company’s ability to meet
Porton Pharma Solutions, a prominent CDMO, has announced a strategic partnership with Aojin to support the development of XDC conjugate drugs. This collaboration encompasses pharmaceutical CMC research and GMP production, with the goal of filing dual IND applications in China
“For us, it’s not a transaction. It really is a partnership,” says Nikki Whitfield, CEO of Upperton Pharma Solutions. Nikki Whitfield brings over three decades of pharmaceutical development experience to her role as CEO of Upperton Pharma Solutions. A chemist
Evotec and Novo Nordisk’s joint translational drug discovery initiative, LAB eN², has announced the selection of its first three research projects and an expansion to include five more leading academic institutions. LAB eN², launched in September 2023, aims to bridge
Lonza has introduced its “One Lonza” strategy during its Investor Update 2024, focusing on the Contract Development and Manufacturing Organisation (CDMO) sector as its core business. The strategy includes a revised organizational structure aimed at streamlining operations, enhancing customer experience,
EUROAPI, a key name in the Active Pharmaceutical Ingredient (API) industry, has announced a significant leadership transition. Emmanuel Blin has been named Independent Chair of the Board of Directors, and David Seignolle assumes the role of Chief Executive Officer, both
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
